<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
</B></FONT><B><FONT STYLE="font-size: 10pt">WASHINGTON, D.C. 20549</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><FONT STYLE="font-size: 10pt">&nbsp;</FONT></B><FONT STYLE="font-size: 10pt"> </FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):&nbsp;<B>
April 17, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B><U>Skinny
Nutritional Corp.<BR>
</U></B></FONT><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COMMISSION FILE NUMBER<B>:&nbsp;&nbsp;<U>0-51313</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Nevada</TD>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">88-0314792</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(State or other jurisdiction of incorporation or organization)</TD>
    <TD STYLE="font-size: 10pt; text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%; font-size: 10pt; font-weight: bold; text-align: center">Three Bala Plaza East, Suite 101</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Bala Cynwyd, PA 19004</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(Address and zip code of principal executive offices)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>(610)
784-2000<BR>
</U></B>(Registrant&rsquo;s telephone number, including area code </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED
        TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR>
</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">1</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR STYLE="mso-special-character: line-break">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 10%; vertical-align: top; font-size: 10pt; font-weight: bold">Item&nbsp;3.02</TD>
    <TD STYLE="width: 90%; padding-left: 8.8pt; font-size: 10pt; font-weight: bold">Unregistered Sales of Equity Securities.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.85pt 0pt 4.3pt">On January 27, 2012, Skinny Nutritional Corp.
        (the &ldquo;Company&rdquo;) filed a Current Report on Form 8-K reporting that it had issued an aggregate of 65,100,000 shares of
        the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;Initial Shares&rdquo;), to Ironridge Global IV, Ltd. (&ldquo;Ironridge&rdquo;),
        in settlement of $1,255,231.64 in <I>bona fide</I> accounts payable of the Company (the &ldquo;Accounts Payable&rdquo;). As previously
        reported, the Initial Shares were issued pursuant to an Order for Approval of Stipulation for Settlement of Claims (the &ldquo;Order&rdquo;)
        between the Company and Ironridge, in settlement of the Accounts Payable which had been purchased by Ironridge from certain creditors.
        In addition, as previously reported, the Order provides that for every ten million shares of the Company&rsquo;s Common Stock that
        trade during the a defined calculation period, or if at any time during such period a daily VWAP is below 80% of the closing price
        on the day before the issuance date, the Company will immediately issue additional shares (each, an &ldquo;Additional Issuance&rdquo;),
        subject to a 9.99% beneficial ownership limitation specified in the Order. Accordingly, pursuant to the adjustment mechanism specified
        in the Order, on April 17, 2012, the Company issued an additional 46,000,000 shares of Common Stock to Ironridge. The Additional
        Issuance was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 3(a)(10)
        thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance
        are approved by a court after a hearing upon the fairness of such terms and conditions.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.85pt 0pt 4.3pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.85pt 0pt 4.3pt">As previously reported, on January 9, 2012, the
        Company&rsquo;s Board of Directors approved the accelerated vesting of an aggregate of 3,575,000 options previously granted by
        the Company under its 2009 Equity Incentive Compensation Plan, including an aggregate of 1,500,000 options held by each of the
        Company&rsquo;s Chief Executive Officer and Chief Financial Officer. In addition, on such date the Company&rsquo;s Board of Directors
        approved the issuance of a total of 2,860,000 restricted shares of common stock to certain employees, including the Company&rsquo;s
        Chief Executive Officer and Chief Financial Officer, subject to the execution by the Company and the covered employees of agreements
        consenting to the cancellation of certain common stock purchase options in consideration of the receipt of such restricted shares
        of common stock. The total number of options covered by this arrangement is 3,575,000 employee stock options which were previously
        granted by the Company under its 2009 Equity Incentive Compensation Plan. The transaction was completed as of April 17, 2012, and
        as of such date, each of the Company&rsquo;s Chief Executive Officer and its Chief Financial Officer received 1,200,000 restricted
        shares of common stock in consideration of the surrender of 1,500,000 options.</P></TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 5pt 11.4pt 5pt 11.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">2</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 42%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 56%; font-weight: bold">Skinny Nutritional Corp.</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">By: &nbsp;&nbsp;&nbsp;&nbsp;/s/ Michael Salaman</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Michael Salaman</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR>
    <TD>&nbsp;Date: &nbsp;&nbsp;April 19, 2012</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">3</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v309948_8k.htm", "secsgml_size_bytes": 14124}]
{"company-data": {"conformed-name": "Skinny Nutritional Corp.", "cik": "0001176325", "assigned-sic": "5141", "irs-number": "233100268", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51313", "film-number": "12769100"}, "business-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004", "phone": "610-784-2000"}, "mail-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004"}, "former-company": {"former-conformed-name": "CREATIVE ENTERPRISES INTERNATIONAL INC", "date-changed": "20020625"}}
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
April 17, 2012
Skinny
Nutritional Corp.
(Exact name of registrant as specified in its charter)
COMMISSION FILE NUMBER
:
0-51313
Nevada
88-0314792
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
Three Bala Plaza East, Suite 101
Bala Cynwyd, PA 19004
(Address and zip code of principal executive offices)
(610)
784-2000
(Registrant's telephone number, including area code
CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED
        TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 3.02
Unregistered Sales of Equity Securities.
On January 27, 2012, Skinny Nutritional Corp.
        (the "Company") filed a Current Report on Form 8-K reporting that it had issued an aggregate of 65,100,000 shares of
        the Company's common stock, par value $0.001 per share (the "Initial Shares"), to Ironridge Global IV, Ltd. ("Ironridge"),
        in settlement of $1,255,231.64 in
bona fide
accounts payable of the Company (the "Accounts Payable"). As previously
        reported, the Initial Shares were issued pursuant to an Order for Approval of Stipulation for Settlement of Claims (the "Order")
        between the Company and Ironridge, in settlement of the Accounts Payable which had been purchased by Ironridge from certain creditors.
        In addition, as previously reported, the Order provides that for every ten million shares of the Company's Common Stock that
        trade during the a defined calculation period, or if at any time during such period a daily VWAP is below 80% of the closing price
        on the day before the issuance date, the Company will immediately issue additional shares (each, an "Additional Issuance"),
        subject to a 9.99% beneficial ownership limitation specified in the Order. Accordingly, pursuant to the adjustment mechanism specified
        in the Order, on April 17, 2012, the Company issued an additional 46,000,000 shares of Common Stock to Ironridge. The Additional
        Issuance was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 3(a)(10)
        thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance
        are approved by a court after a hearing upon the fairness of such terms and conditions.
As previously reported, on January 9, 2012, the
        Company's Board of Directors approved the accelerated vesting of an aggregate of 3,575,000 options previously granted by
        the Company under its 2009 Equity Incentive Compensation Plan, including an aggregate of 1,500,000 options held by each of the
        Company's Chief Executive Officer and Chief Financial Officer. In addition, on such date the Company's Board of Directors
        approved the issuance of a total of 2,860,000 restricted shares of common stock to certain employees, including the Company's
        Chief Executive Officer and Chief Financial Officer, subject to the execution by the Company and the covered employees of agreements
        consenting to the cancellation of certain common stock purchase options in consideration of the receipt of such restricted shares
        of common stock. The total number of options covered by this arrangement is 3,575,000 employee stock options which were previously
        granted by the Company under its 2009 Equity Incentive Compensation Plan. The transaction was completed as of April 17, 2012, and
        as of such date, each of the Company's Chief Executive Officer and its Chief Financial Officer received 1,200,000 restricted
        shares of common stock in consideration of the surrender of 1,500,000 options.
2
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
Skinny Nutritional Corp.
By:     /s/ Michael Salaman
Name: Michael Salaman
Title:   Chief Executive Officer
Date:   April 19, 2012
3